CoChat

From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors

Open access
Massari, Serena, Corona, Angela, Distinto, Simona, Desantis, Jenny, Caredda, Alessia, Sabatini, Stefano, Manfroni, Giuseppe, Felicetti, Tommaso, Cecchetti, Violetta, Pannecouque, Christophe, Maccioni, Elias, Tramontano, Enzo, Tabarrini, Oriana · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
Cited by 19

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The paper focussed on a step-by-step structural modification of a cycloheptathiophene-3-carboxamide derivative recently identified by us as reverse transcriptase (RT)-associated ribonuclease H (RNase H) inhibitor. In particular, its conversion to a 2-aryl-cycloheptathienoozaxinone derivative and the successive thorough exploration of both 2-aromatic and cycloheptathieno moieties led to identify oxazinone-based compounds as new anti-RNase H chemotypes. The presence of the catechol moiety at the C-2 position of the scaffold emerged as critical to achieve potent anti-RNase H activity, which also encompassed anti-RNA dependent DNA polymerase (RDDP) activity for the tricyclic derivatives. Benzothienooxazinone derivative 22 resulted the most potent dual inhibitor exhibiting IC50s of 0.53 and 2.90 μM against the RNase H and RDDP functions. Mutagenesis and docking studies suggested that compound 22 binds two allosteric pockets within the RT, one located between the RNase H active site and the primer grip region and the other close to the DNA polymerase catalytic centre.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/14756366.2018.1523901

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 19

Metadata

Authors
Massari, S., Corona, A., Distinto, S., Desantis, J., Caredda, A., Sabatini, S., Manfroni, G., Felicetti, T., Cecchetti, V., Pannecouque, C., Maccioni, E., Tramontano, E., & Tabarrini, O.
Venue
Journal of Enzyme Inhibition and Medicinal Chemistry
Published
2018-10-26
Volume
34
Issue
1
Pages
55-74
ISSN
  • 1475-6366 (ISSN-L)
  • 1475-6374
OpenAlex
W2898395458
Cited by
19
References
4
FWCI
2.07
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors. https://app.cochat.ai/papers/10.1080/14756366.2018.1523901
The paper
Massari, S., Corona, A., Distinto, S., Desantis, J., Caredda, A., Sabatini, S., Manfroni, G., Felicetti, T., Cecchetti, V., Pannecouque, C., Maccioni, E., Tramontano, E., & Tabarrini, O. (2019). From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2018.1523901

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.